U.S. and European severe asthma cohorts: what can they teach us about severe asthma?

Abstract excerpt

Asthma is a global health problem affecting around 300 million patients of all ages and ethnic groups in all countries around the world. In the majority of subjects with persistent, mild-to-moderate asthma (MA), the disease can be relatively well controlled by the use of currently available medications; however, five to ten per cent of patients suffer from a particularly severe disease that is poorly controlled...

Topics

• Adult
• Anti-Asthmatic Agents
• Asthma
• Child
• Cross-Sectional Studies
• Drug Resistance
• Europe
• Global Health
• Humans
• International Cooperation
• Longitudinal Studies
• Phenotype